Microarray analysis of gene expression after transverse aortic constriction in mice

Physiological Genomics

Volumn 19, Issue , 2005, Pages 93-105

  Zhao, Mingming ^a   Chow, Amy ^a   Powers, Jennifer ^a   Fajardo, Giovanni ^a   Bernstein, Daniel ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Apoptosis; Cardiac hypertrophy; Proliferation; Signal transduction

Indexed keywords

KI 67 ANTIGEN; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; ISOLATED HEART; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; STATISTICAL ANALYSIS; TIME; UNINDEXED SEQUENCE; UPREGULATION;

ACUTE DISEASE; ALGORITHMS; ANESTHESIA; ANIMALS; AORTA; BODY WEIGHT; CARDIOMEGALY; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; STRESS; TIME FACTORS;

ANIMALIA; MURINAE;

EID: 11144320715     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00040.2004     Document Type: Article

References (51)

1. Akiyama Y, Ashizawa N, Seto S, Ohtsuru A, Kuroda H, Ito M, Yamashita S, and Yano K. Involvement of receptor-type tyrosine kinase gene families in cardiac hypertrophy. J Hypertens 17: 1329-1337, 1999.
2. Ball CA, Sherlock G, Parkinson H, Rocca-Sera P, Brooksbank C, Causton HC, Cavalieri D, Gaasterland T, Hingamp P, Holstege F, Ringwald M, Spellman P, Stoeckert CJ Jr, Stewart JE, Taylor R, Brazma A, and Quackenbush J. The underlying principles of scientific publication. Bioinformatics 18: 1409, 2002.
3. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, and Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750-1757, 2001.
4. Bocker W, Hupf H, Grimm D, Kurzidim K, and Schunkert H. Effects of indapamide in rats with pressure overload left ventricular hypertrophy. J Cardiovasc Pharmacol 36: 481-486, 2000.
5. Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, Crow MT, and Lakatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 75: 23-32, 1994.
6. Bourdon JC, Renzing J, Robertson PL, Fernandes KN, and Lane DP. Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane. J Cell Biol 158: 235-246, 2002.
7. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, and Vingron M. Minimum information about a microarray experiment (MIAME): toward standards for microarray data. Nat Genet 29: 365-371, 2001.
8. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky K, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, and Molkentin JD. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19: 6341-6350, 2000.
9. Busk PK, Bartkova J, Strom CC, Wulf-Andersen L, Hinrichsen R, Christoffersen TE, Latella L, Bartek J, Haunso S, and Sheikh SP. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res 56: 64-75, 2002.
10. CardioGenomics PGA. Pressure-Overload Induced Cardiac Hypertrophy. http://cardiogenomics.med.harvard.edu/groups/proj1/pages/band_phys.html (11 March 2004).
11. Chen G, Cizeau J, Vande Velde C, Park JH, Bozek G, Bolton J, Shi L, Dubik D, and Greenberg A. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J Biol Chem 274: 7-10, 1999.
12. Colotta F, Polentarutti N, Sironi M, and Mantovani A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267: 18278-18283, 1992.
13. Condorelli G, Morisco C, Stassi G, Notte A, Farina F, Sgaramella G, de Rienzo A, Roncarati R, Trimarco B, and Lembo G. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99: 3071-3078, 1999.
14. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, and Franzoso G. Induction of gadd45β by NFκB downregulates pro-apoptotic JNK signalling. Nature 414: 308-313, 2001.
15. Dierick H and Bejsovec A. Cellular mechanisms of wingless/Wnt signal transduction. Curr Top Dev Biol 43: 153-190, 1999.
16. Donohue TJ, Dworkin LD, Ma J, Lango MN, and Catanese VM. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I. J Investig Med 45: 584-591, 1997.
17. Firestein GS and Pisetsky DS. DNA microarrays: boundless technology or bound by technology? Guidelines for studies using microarray technology. Arthritis Rheum 46: 859-861, 2002.
18. Hu E, Zhu Y, Fredrickson T, Barnes M, Kelsell D, Beeley L, and Brooks D. Tissue restricted expression of two human Frzbs in preadipocytes and pancreas. Biochem Biophys Res Commun 247: 287-293, 1998.
19. Janssen PM, Hasenfuss G, Zeitz O, Lehnart SE, Prestle J, Darmer D, Holtz J, and Schumann H. Load-dependent induction of apoptosis in multicellular myocardial preparations. Am J Physiol Heart Circ Physiol 282: H349-H356, 2002; doi:10.1152/ajpheart.00024.2001.
20. Kaiser M, Kahr O, Shimada Y, Smith P, Kelly M, Mahadeva H, Adams M, Lodwick D, Aalkjaer C, Avkiran M, and Samani NJ. Differential regulation of ventricular adrenomedullin and atrial natriuretic peptide gene expression in pressure and volume overload in the rat. Clin Sci (Lond) 94: 359-365, 1998.
21. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, and Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 95: 8801-8805, 1998.
22. Kessler-Icekson G, Barhum Y, Schlesinger H, Shohat J, Sharma H, and Schaper W. Molecular manifestations of cardiac hypertrophy in the spontaneously hypertensive rat effects of antihypertensive treatments. Adv Exp Med Biol 382: 195-203, 1995.
23. Kitsberg D, Formstecher E, Fauquet M, Kubes M, Cordier J, Canton B, Pan G, Rolli M, Glowinski J, and Chneiweiss H. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFα-induced apoptosis. J Neurosci 19: 8244-8251, 1999.
24. Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, and Conway SJ. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 103: 183-188, 2001.
25. Lee ML, Kuo FC, Whitmore GA, and Sklar J. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci USA 97: 9834-9839, 2000.
26. Leri A, Barlucchi L, Limana F, Deptala A, Darzynkiewicz Z, Hintze TH, Kajstura J, Nadal-Ginard B, and Anversa P. Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc Natl Acad Sci USA 98: 8626-8631, 2001.
27. Li P, Chen PM, Wang SW, and Chen LY. Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload. Hypertens Res 25: 757-762, 2002.
28. MacCallum DE and Hall PA. The biochemical characterization of the DNA binding activity of pKi67. J Pathol 191: 286-298, 2000.
29. Mirotsou M, Watanabe CM, Schultz PG, Pratt RE, and Dzau VJ. Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. Physiol Genomics 15: 115-126, 2003. First published August 5, 2003; doi:10.1152/physiolgenomics.00071. 2003.
30. Nediani C, Celli A, Formigli L, Perna AM, Fiorillo C, Ponziani V, Ibba-Manneschi L, Zecchi-Orlandini S, Nosi D, Liguri G, Modesti PA, and Nassi P. Possible role of acylphosphatase, Bcl-2 and Fas/Fas-L system in the early changes of cardiac remodeling induced by volume overload. Biochim Biophys Acta 1638: 217-226, 2003.
31. Ogawa T, Linz W, Stevenson M, Bruneau BG, Kuroski de Bold ML, Chen JH, Eid H, Scholkens BA, and de Bold AJ. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation 93: 2059-2067, 1996.
32. Olivetti G, Melissari M, Balbi T, Quaini F, Sonnenblick EH, and Anversa P. Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J Am Coll Cardiol 24: 140-149, 1994.
33. Oltvai ZN, Milliman CL, and Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
34. Pan W, Lin J, and Le CT. A mixture model approach to detecting differentially expressed genes with microarray data. Funct Integr Genomics 3: 117-124, 2003.
35. +-ATPase by ouabain induces the Ca2+-dependent expressions of early-response genes in cardiac myocytes. J Biol Chem 271: 10372-10378, 1996.
36. Pollock JD. Gene expression profiling: methodological challenges, results, and prospects for addiction research. Chem Phys Lipids 121: 241-256, 2002.
37. Rajeevan MS, Vernon SD, Taysavang N, and Unger ER. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 3: 26-31, 2001.
38. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, and Chien KR. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88: 8277-8281, 1991.
39. Rockman HA, Wachhorst SP, Mao L, and Ross J Jr. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol Heart Circ Physiol 266: H2468-H2475, 1994.
40. Schluter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, and Gerdes J. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 123: 513-522, 1993.
41. Scholzen T and Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311-322, 2000.
42. Schumann H, Holtz J, Zerkowski HR, and Hatzfeld M. Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression. Cardiovasc Res 45: 720-728, 2000.
43. Steele FR, Chader GJ, Johnson LV, and Tombran-Tink J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA 90: 1526-1530, 1993.
44. Troyanskaya OG, Garber ME, Brown PO, Botstein D, and Altman RB. Nonparametric methods for identifying differentially expressed genes in microarray data. Bioinformatics 18: 1454-1461, 2002.
45. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ, and Vaux DL. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277: 445-454, 2002.
46. Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, and Bouck NP. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 8: 349-357, 2002.
47. Weinberg EO, Mirotsou M, Gannon J, Dzau VJ, Lee RT, and Pratt RE. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics 12: 113-127, 2003. First published November 26, 2002; doi:10.1152/physiolgenomics. 00046.2002.
48. Wollert KC and Drexler H. Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis. Heart Fail Rev 7: 317-325, 2002.
49. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW, and Mak TW. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12: 806-819, 1998.
50. Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L, Mitchell CA, Young JB, Francis GS, McCarthy PM, and Bond M. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102: 3046-3052, 2000.
51. Yussman MG, Toyokawa T, Odley A, Lynch RA, Wu G, Colbert MC, Aronow BJ, Lorenz JN, and Dorn GW II. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 8: 725-730, 2002.